{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:53:44Z","timestamp":1789570424811,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.taap.2025.117317","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T16:42:28Z","timestamp":1743612148000},"page":"117317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pectin-loaded ferulic acid nanoparticles: A potential therapeutic strategy for ulcerative colitis via modulation of the cGAS-STING pathway"],"prefix":"10.1016","volume":"499","author":[{"given":"Jingwen","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengshu","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanlong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117317_bb0005","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MOG.0000000000000031","article-title":"Treatment of ulcerative colitis","volume":"30","author":"Blonski","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.taap.2025.117317_bb0010","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ueg2.12442","article-title":"Review article: updated management of acute severe ulcerative colitis: from steroids to novel medical strategies","volume":"11","author":"Calm\u00e9jane","year":"2023","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.taap.2025.117317_bb0015","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.7150\/ijbs.67356","article-title":"Atrial natriuretic peptide attenuates colitis via inhibition of the cGAS-STING pathway in colonic epithelial cells","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2025.117317_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176122","article-title":"IGF2\/IGF2R\/Sting signaling as a therapeutic target in DSS-induced ulcerative colitis","volume":"960","author":"Chen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117317_bb0025","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.crohns.2014.05.008","article-title":"Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis","volume":"8","author":"Childers","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.taap.2025.117317_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2013.06.007","article-title":"Involvement of JAK\/STAT signaling in the pathogenesis of inflammatory bowel disease","volume":"76","author":"Coskun","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2025.117317_bb0035","article-title":"Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience","volume":"12","author":"D'Amico","year":"2019","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.taap.2025.117317_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120814","article-title":"Pectin based multi-particulate carriers for colon-specific delivery of therapeutic agents","volume":"605","author":"Das","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2025.117317_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1590\/S1984-82502013000300002","article-title":"Ferulic acid and derivatives: molecules with potential application in the pharmaceutical field","volume":"49","author":"de Paiva","year":"2013","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2025.117317_bb0050","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","article-title":"Cyclic [G(2\u2032,5\u2032)pA(3\u2032,5\u2032)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase","volume":"153","author":"Gao","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.taap.2025.117317_bb0055","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ijbiomac.2022.11.062","article-title":"Fucoidan-ferulic acid nanoparticles alleviate cisplatin-induced acute kidney injury by inhibiting the cGAS-STING pathway","volume":"223","author":"Gao","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.taap.2025.117317_bb0060","doi-asserted-by":"crossref","first-page":"1351538","DOI":"10.3389\/fphar.2024.1351538","article-title":"Quercetin ameliorates ulcerative colitis by restoring the balance of M2\/M1 and repairing the intestinal barrier via downregulating cGAS-STING pathway","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2025.117317_bb0065","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s10787-023-01277-y","article-title":"Ferulic acid ameliorates ulcerative colitis in a rat model via the inhibition of two LPS-TLR4-NF-\u03baB and NF-\u03baB-INOS-NO signaling pathways and thus alleviating the inflammatory, oxidative and apoptotic conditions in the colon tissue","volume":"31","author":"Ghasemi-Dehnoo","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2025.117317_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1358\/dot.2015.51.3.2298240","article-title":"Golimumab: clinical update on its use for ulcerative colitis","volume":"51","author":"Gilardi","year":"2015","journal-title":"Drugs Today"},{"key":"10.1016\/j.taap.2025.117317_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.intimp.2017.06.022","article-title":"Protective, effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice","volume":"50","author":"Gu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2025.117317_bb0080","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00011-011-0325-6","article-title":"PI3K\/Akt signaling pathway is involved in the pathogenesis of ulcerative colitis","volume":"60","author":"Huang","year":"2011","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.taap.2025.117317_bb0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.taap.2025.117317_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.colsurfb.2012.11.042","article-title":"Pectin and charge modified pectin hydrogel beads as a colon-targeted drug delivery carrier","volume":"104","author":"Jung","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.taap.2025.117317_bb0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/jcm9010094","article-title":"Ulcerative colitis: current and emerging treatment strategies","volume":"9","author":"Kayal","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.taap.2025.117317_bb0100","article-title":"Pharmaceutical and drug delivery applications of pectin and its modified nanocomposites","volume":"8","author":"Kedir","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.taap.2025.117317_bb0105","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijbiomac.2020.05.002","article-title":"Pectin polymers for colon-targeted antitumor drug delivery","volume":"158","author":"Khotimchenko","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.taap.2025.117317_bb0110","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2174\/138945011796818117","article-title":"Natural history of ulcerative colitis: current knowledge","volume":"12","author":"Kiss","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.taap.2025.117317_bb0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, practice parameters committee","volume":"105","author":"Kornbluth","year":"2010","journal-title":"Off. J. Am. Coll. Gastroenterol."},{"key":"10.1016\/j.taap.2025.117317_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2014.07.022","article-title":"Quantitative image analysis tool to study the plasma membrane localization of proteins and cortical actin in neuroendocrine cells","volume":"236","author":"Kurps","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.taap.2025.117317_bb0125","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.7150\/ijbs.94548","article-title":"Neuropeptide substance P attenuates colitis by suppressing inflammation and ferroptosis via the cGAS-STING signaling pathway","volume":"20","author":"Lan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2025.117317_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijbiomac.2021.06.088","article-title":"Pectin in biomedical and drug delivery applications: a review","volume":"185","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.taap.2025.117317_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117317_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13020-020-0296-z","article-title":"Targeting NF-\u03baB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines","volume":"15","author":"Lu","year":"2020","journal-title":"Chin. Med."},{"key":"10.1016\/j.taap.2025.117317_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1168990","article-title":"Natural flavones from edible and medicinal plants exhibit enormous potential to treat ulcerative colitis","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2025.117317_bb0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00281-019-00751-6","article-title":"Resolution of ulcerative colitis","volume":"41","author":"Neurath","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.taap.2025.117317_bb0155","series-title":"Ferulic Acid\u2014A Brief Review of Its Extraction, Bioavailability and Biological Activity. Separations","first-page":"204","volume":"11","author":"Pyrzynska","year":"2024"},{"key":"10.1016\/j.taap.2025.117317_bb0160","first-page":"482","article-title":"Ferulic acid ameliorates TNBS-induced ulcerative colitis through modulation of cytokines, oxidative stress, INOS, COX-2, and apoptosis in laboratory rats","volume":"15","author":"Sadar","year":"2016","journal-title":"EXCLI J."},{"key":"10.1016\/j.taap.2025.117317_bb0165","article-title":"Ferulic acid-loaded drug delivery systems for biomedical applications","volume":"75","author":"Shukla","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.taap.2025.117317_bb0170","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.3390\/jcm9082646","article-title":"Early intervention in ulcerative colitis: ready for prime time?","volume":"9","author":"Solitano","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.taap.2025.117317_bb0175","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.3390\/ijms222312889","article-title":"Recent advances in biological activity, new formulations and prodrugs of ferulic acid","volume":"22","author":"Stompor-Gor\u0105cy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117317_bb0180","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.3390\/molecules28247974","article-title":"Biological properties and biomedical applications of pectin and pectin-based composites: a review","volume":"28","author":"Sultana","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.taap.2025.117317_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113358","article-title":"Neutrophil extracellular traps induce barrier dysfunction in DSS-induced ulcerative colitis via the cGAS-STING pathway","volume":"143","author":"Sun","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2025.117317_bb0190","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2025.117317_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00365513.2012.734859","article-title":"N-acetylcysteine expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic acid-induced colitis in rats","volume":"73","author":"Uraz","year":"2013","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.taap.2025.117317_bb0200","first-page":"4477","article-title":"Costus root granules improve ulcerative colitis through regulation of TGF-\u03b2 mediation of the PI3K\/AKT signaling pathway","volume":"15","author":"Wang","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.taap.2025.117317_bb0205","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/08923973.2018.1469145","article-title":"Curcumin as a therapeutic agent for blocking NF-\u03baB activation in ulcerative colitis","volume":"40","author":"Wang","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.taap.2025.117317_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114086","article-title":"The role and mechanism of flavonoid herbal natural products in ulcerative colitis","volume":"158","author":"Xue","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2025.117317_bb0215","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cbin.11935","article-title":"Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP\/NLRP3 pathway in rats","volume":"47","author":"Yu","year":"2023","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.taap.2025.117317_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cbin.11935","article-title":"Ferulic acid relieved ulcerative colitis by inhibiting the TXNIP\/NLRP3 pathway in rats","volume":"47","author":"Yu","year":"2023","journal-title":"Cell Biol. Int."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:13:13Z","timestamp":1777457593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":44,"alternative-id":["S0041008X25000936"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117317","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pectin-loaded ferulic acid nanoparticles: A potential therapeutic strategy for ulcerative colitis via modulation of the cGAS-STING pathway","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117317"}}